AKYA Akoya Biosciences Inc
Price (delayed)
$1.35
Market cap
$67.25M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.12
Enterprise value
$138.93M
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive
Highlights
Akoya Biosciences's EPS has increased by 22% YoY and by 3.4% from the previous quarter
Akoya Biosciences's net income has increased by 13% YoY and by 4.5% QoQ
The equity has dropped by 86% year-on-year and by 44% since the previous quarter
The company's quick ratio fell by 41% YoY and by 4.5% QoQ
Key stats
What are the main financial stats of AKYA
Market
Valuations
Earnings
Shares outstanding
49.82M
Market cap
$67.25M
Enterprise value
$138.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.81
Price to sales (P/S)
0.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.7
Revenue
$81.67M
Gross profit
$47.88M
Operating income
-$47.24M
Net income
-$55.37M
EBIT
-$44.79M
EBITDA
-$37.14M
Free cash flow
-$46.56M
Per share
Balance sheet
Liquidity
EPS
-$1.12
EPS diluted
-$1.12
Free cash flow per share
-$0.94
Book value per share
$0.15
Revenue per share
$1.65
TBVPS
$1.87
Total assets
$125.01M
Total liabilities
$117.41M
Debt
$84.15M
Equity
$7.6M
Working capital
$47.29M
Debt to equity
11.08
Current ratio
2.61
Quick ratio
1.68
Net debt/EBITDA
-1.93
Margins
Efficiency
Dividend
EBITDA margin
-45.5%
Gross margin
58.6%
Net margin
-67.8%
Operating margin
-57.8%
Return on assets
-40%
Return on equity
-290.6%
Return on invested capital
-30.7%
Return on capital employed
-46.9%
Return on sales
-54.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AKYA stock price
How has the Akoya Biosciences stock price performed over time
Intraday
-2.88%
1 week
-12.34%
1 month
-17.18%
1 year
-70.39%
YTD
-41.05%
QTD
-2.88%
Financial performance
How have Akoya Biosciences's revenue and profit performed over time
Revenue
$81.67M
Gross profit
$47.88M
Operating income
-$47.24M
Net income
-$55.37M
Gross margin
58.6%
Net margin
-67.8%
The company's operating income rose by 16% YoY and by 6% QoQ
The revenue has decreased by 15% YoY and by 6% QoQ
The gross profit has declined by 15% year-on-year and by 4.5% since the previous quarter
Akoya Biosciences's net income has increased by 13% YoY and by 4.5% QoQ
Growth
What is Akoya Biosciences's growth rate over time
Valuation
What is Akoya Biosciences stock price valuation
P/E
N/A
P/B
8.81
P/S
0.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.7
Akoya Biosciences's EPS has increased by 22% YoY and by 3.4% from the previous quarter
The equity has dropped by 86% year-on-year and by 44% since the previous quarter
AKYA's price to book (P/B) is 2.5% lower than its last 4 quarters average of 9.3
The price to sales (P/S) is 51% lower than the last 4 quarters average of 1.7
The revenue has decreased by 15% YoY and by 6% QoQ
Efficiency
How efficient is Akoya Biosciences business performance
The ROE has plunged by 164% YoY and by 53% from the previous quarter
The return on invested capital is up by 43% year-on-year and by 10% since the previous quarter
Akoya Biosciences's return on assets has decreased by 11% YoY and by 5% QoQ
Akoya Biosciences's ROS has increased by 2.8% YoY
Dividends
What is AKYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AKYA.
Financial health
How did Akoya Biosciences financials performed over time
AKYA's total assets is 6% greater than its total liabilities
The company's quick ratio fell by 41% YoY and by 4.5% QoQ
AKYA's total assets is down by 31% year-on-year and by 3.8% since the previous quarter
The equity has dropped by 86% year-on-year and by 44% since the previous quarter
Akoya Biosciences's debt to equity has soared by 78% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.